Randomised controlled clinical trial of standard versus echocardiographically guided ibuprofen treatment for patent ductus arteriosus in preterm infants: A pilot study

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 9, 2014, Pages 904-909

  Bravo, María Carmen ^a   Cabañas, Fernando ^a   Riera, Joan ^a,b   Pérez Fernández, Elia ^a   Quero, José ^a   Pérez Rodríguez, Jesús ^a   Pellicer, Adelina ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

Author keywords

Cyclooxygenase inhibitor; Functional echocardiography; Newborn

Indexed keywords

IBUPROFEN;

ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR PROCEDURE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSE INCREASE; DRUG WITHDRAWAL; DUCTUS ARTERIOSUS REOPENING RATE; ECHOCARDIOGRAPHICALLY GUIDED TREATMENT; ECHOCARDIOGRAPHY; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; INTERMETHOD COMPARISON; INTESTINE ISCHEMIA; INTRAVASCULAR ULTRASOUND SYSTEM; MALE; NEWBORN; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STANDARD TREATMENT; DOSE RESPONSE; DUCTUS ARTERIOSUS, PATENT; ECHOGRAPHY; GESTATIONAL AGE; HEALTH CARE QUALITY; INFANT, PREMATURE, DISEASES; PREMATURITY;

DOSE-RESPONSE RELATIONSHIP, DRUG; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY; FEMALE; GESTATIONAL AGE; HUMANS; IBUPROFEN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTENTION TO TREAT ANALYSIS; MALE; PILOT PROJECTS; STANDARD OF CARE;

EID: 84901044138     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.846312     Document Type: Article

References (28)

1. Noori S, McCoy M, Friedlich P, et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 2009; 123: 138-44.
2. Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2010; 7: CD000174.
3. Mosalli R, Alfaleh K. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. Cochrane Database Syst Rev 2008; 1: CD006181.
4. Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2011; 7: CD004213.
5. Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 2010; 30: 241-52.
6. Jones LJ, Craven PD, Attia J, et al. Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants. Arch Dis Child Fetal Neonatal Ed 2011; 96: F45-52.
7. Sosenko IR, Fajardo MF, Claure N, Bancalari E. Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial. J Pediatr 2012; 160: 929-35.e1.
8. McNamara PJ, Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed 2007; 92: F424-7.
9. Carmo KB, Evans N, Paradisis M. Duration of indomethacin treatment of the preterm patent ductus arteriosus as directed by echocardiography. J Pediatr 2009; 155: 819-822.
10. Su BH, Peng CT, Tsai CH. Echocardiographic flow pattern of patent ductus arteriosus: a guide to indomethacin treatment in premature infants. Arch Dis Child Fetal Neonatal Ed 1999; 81: F197-200.
11. Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2010; 4: CD003481.
12. Pezzati M, Vangi V, Biagiotti R, et al. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 1999; 135: 733-8.
13. Mosca F, Bray M, Lattanzio M, et al. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 1997; 131: 549-54.
14. Speziale MV, Allen RG, Henderson CR, et al. Effects of ibuprofen and indomethacin on the regional circulation in newborn piglets. Biol Neonate 1999; 76: 242-52.
15. Evans N, Moorcraft J. Effect of patency of the ductus arteriosus on blood pressure in very preterm infants. Arch Dis Child 1992; 67: 1169-73.
16. El-Khuffash AF, Amoruso M, Culliton M, Molloy EJ. N-terminal pro-B-type natriuretic peptide as a marker of ductal hemodynamic significance in preterm infants: a prospective observational study. Arch Dis Child Fetal Neonatal Ed 2007; 92: F421-2.
17. Perlman JM, Hill A, Volpe JJ. The effect of patent ductus arteriosus on flow velocity in the anterior cerebral arteries: ductal steal in the premature newborn infant. J Pediatr 1981; 99: 767-71.
18. Evans N. Diagnosis of the preterm patent ductus arteriosus: clinical signs, biomarkers, or ultrasound? Semin Perinatol 2012; 36: 114-22.
19. Skelton R, Evans N, Smythe J. A blinded comparison of clinical and echocardiographic evaluation of the preterm infant for patent ductus arteriosus. J Paediatr Child Health 1994; 30: 406-11.
20. Herrman K, Bose C, Lewis K, Laughon M. Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child Fetal Neonatal Ed 2009; 94: F48-50.
21. Noori S. Pros and cons of patent ductus arteriosus ligation: hemodynamic changes and other morbidities after patent ductus arteriosus ligation. Semin Perinatol 2012; 36: 139-45.
22. Kluckow M, Evans N. Superior vena cava flow in newborn infants: a novel marker of systemic blood flow. Arch Dis Child Fetal Neonatal Ed 2000; 82: F182-7.
23. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
24. Su BH, Peng CT, Tsai CH. Persistent pulmonary hypertension of the newborn: echocardiographic assessment. Acta Paediatr Taiwan 2001; 42: 218-23.
25. Romagnoli C, Giannantonio C, De Carolis MP, et al. Neonatal color Doppler US study: normal values of cerebral blood flow velocities in preterm infants in the first month of life. Ultrasound Med Biol 2006; 32: 321-31.
26. Weiss H, Cooper B, Brook M, et al. Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin. J Pediatr 1995; 127: 466-71.
27. Aranda JV, Clyman R, Cox B, et al. A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birh in extremely low-birth-weight infants. Am J Perinatol 2009; 26: 235-45.
28. Harling S, Hansen-Pupp I, Baigi A, Pesonen E. Echocardiographic prediction of patent ductus arteriosus in need of therapeutic intervention. Acta Paediatr 2011; 100: 231-5.